Literature DB >> 16281665

Measurement of dyspnea in chronic obstructive pulmonary disease: what is the tool telling you?

P M Meek1.   

Abstract

AIMS: Dyspnea is the most common symptom experienced by patients with chronic obstructive pulmonary disease (COPD) and is linked to decreases in patient activity levels and quality of life. Use of standardized tools to measure dyspnea has a long history in respiratory care. However, in many cases it is not clear what is being quantified when using a particular tool. This review will consider the definition of and mechanisms believed to contribute to dyspnea, attempting to clarify what is being quantified in common tools currently available for dyspnea measurement.

Entities:  

Mesh:

Year:  2004        PMID: 16281665     DOI: 10.1191/1479972304cd008ra

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  4 in total

1.  Reliability and validity of the multidimensional dyspnea profile.

Authors:  Paula M Meek; Robert Banzett; Mark B Parsall; Richard H Gracely; Richard M Schwartzstein; Robert Lansing
Journal:  Chest       Date:  2012-01-19       Impact factor: 9.410

2.  Outcome measurement for COPD: reliability and validity of the Dyspnea Management Questionnaire.

Authors:  Anna Norweg; Alan M Jette; Pengsheng Ni; Jonathan Whiteson; Minjin Kim
Journal:  Respir Med       Date:  2010-09-29       Impact factor: 3.415

3.  Feasibility of Using Daily Home High-Flow Nasal Therapy in COPD Patients Following a Recent COPD Hospitalization.

Authors:  Gerard J Criner; Lii-Yoong H Criner; Sheril A George; Jiji K Thomas; Michael R Jacobs
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

4.  Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.

Authors:  D J A Janssen; E F M Wouters; Y Lozano Parra; K Stakenborg; F M E Franssen
Journal:  BMC Pulm Med       Date:  2016-04-06       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.